203 related articles for article (PubMed ID: 34697839)
1. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects.
Abadi AJ; Mirzaei S; Mahabady MK; Hashemi F; Zabolian A; Hashemi F; Raee P; Aghamiri S; Ashrafizadeh M; Aref AR; Hamblin MR; Hushmandi K; Zarrabi A; Sethi G
Phytother Res; 2022 Jan; 36(1):189-213. PubMed ID: 34697839
[TBL] [Abstract][Full Text] [Related]
2. Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity.
Ashrafizadeh M; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Bagherian M; Azami N; Bejandi AK; Hushmandi K; Ang HL; Makvandi P; Khan H; Kumar AP
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33187385
[TBL] [Abstract][Full Text] [Related]
3. Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity.
Rezaee R; Momtazi AA; Monemi A; Sahebkar A
Pharmacol Res; 2017 Mar; 117():218-227. PubMed ID: 28042086
[TBL] [Abstract][Full Text] [Related]
4. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC
Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy.
Mirzaei S; Gholami MH; Zabolian A; Saleki H; Bagherian M; Torabi SM; Sharifzadeh SO; Hushmandi K; Fives KR; Khan H; Ashrafizadeh M; Zarrabi A; Bishayee A
Curr Mol Pharmacol; 2023 Feb; 16(3):280-306. PubMed ID: 35430977
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance.
Mirzaei S; Mohammadi AT; Gholami MH; Hashemi F; Zarrabi A; Zabolian A; Hushmandi K; Makvandi P; Samec M; Liskova A; Kubatka P; Nabavi N; Aref AR; Ashrafizadeh M; Khan H; Najafi M
Pharmacol Res; 2021 May; 167():105575. PubMed ID: 33771701
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.
Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; D'Alessandro N
Cancer Lett; 2005 Jun; 224(1):53-65. PubMed ID: 15911101
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
Wang YT; Liu HS; Su CL
Int J Food Sci Nutr; 2014 May; 65(3):368-74. PubMed ID: 24438326
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of curcumin and cisplatin via down-regulation of thymidine phosphorylase and excision repair cross-complementary 1 (ERCC1).
Tsai MS; Weng SH; Kuo YH; Chiu YF; Lin YW
Mol Pharmacol; 2011 Jul; 80(1):136-46. PubMed ID: 21493726
[TBL] [Abstract][Full Text] [Related]
10. Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.
Montopoli M; Ragazzi E; Froldi G; Caparrotta L
Cell Prolif; 2009 Apr; 42(2):195-206. PubMed ID: 19236381
[TBL] [Abstract][Full Text] [Related]
11. Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy.
Mirzaei S; Gholami MH; Hashemi F; Zabolian A; Hushmandi K; Rahmanian V; Entezari M; Girish YR; Sharath Kumar KS; Aref AR; Makvandi P; Ashrafizadeh M; Zarrabi A; Khan H
Life Sci; 2021 Jul; 277():119430. PubMed ID: 33789144
[TBL] [Abstract][Full Text] [Related]
12. Versatile role of curcumin and its derivatives in lung cancer therapy.
Ashrafizadeh M; Najafi M; Makvandi P; Zarrabi A; Farkhondeh T; Samarghandian S
J Cell Physiol; 2020 Dec; 235(12):9241-9268. PubMed ID: 32519340
[TBL] [Abstract][Full Text] [Related]
13. Curcumin-cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects.
Hussain Y; Islam L; Khan H; Filosa R; Aschner M; Javed S
Phytother Res; 2021 Dec; 35(12):6514-6529. PubMed ID: 34347326
[TBL] [Abstract][Full Text] [Related]
14. Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells.
Mendonça LM; da Silva Machado C; Teixeira CC; de Freitas LA; Bianchi Mde L; Antunes LM
Neurotoxicology; 2013 Jan; 34():205-11. PubMed ID: 23036615
[TBL] [Abstract][Full Text] [Related]
15. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies.
Mirzaei S; Hushmandi K; Zabolian A; Saleki H; Torabi SMR; Ranjbar A; SeyedSaleh S; Sharifzadeh SO; Khan H; Ashrafizadeh M; Zarrabi A; Ahn KS
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921908
[TBL] [Abstract][Full Text] [Related]
16. Effect of concomitant treatment of curcumin and melatonin on cisplatin-induced nephrotoxicity in rats.
Ali BH; Abdelrahman A; Al Suleimani Y; Manoj P; Ali H; Nemmar A; Al Za'abi M
Biomed Pharmacother; 2020 Nov; 131():110761. PubMed ID: 33152924
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin Chemotherapy and Cochlear Damage: Otoprotective and Chemosensitization Properties of Polyphenols.
Fetoni AR; Paciello F; Troiani D
Antioxid Redox Signal; 2022 Jun; 36(16-18):1229-1245. PubMed ID: 34731023
[No Abstract] [Full Text] [Related]
18. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
[TBL] [Abstract][Full Text] [Related]
19. A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer.
Kumar B; Yadav A; Hideg K; Kuppusamy P; Teknos TN; Kumar P
PLoS One; 2014; 9(3):e93208. PubMed ID: 24675768
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.
Sivanantham B; Sethuraman S; Krishnan UM
ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
